Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE8878.7552.05 (+0.59 %)

PREV CLOSE ( ) 8826.70

OPEN PRICE ( ) 8751.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 725

TODAY'S LOW / HIGH ( )8650.00 8990.00

52 WK LOW / HIGH ( )6501.6 10653.05

NSE8919.0095 (+1.08 %)

PREV CLOSE( ) 8824.00

OPEN PRICE ( ) 8829.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 8919.00 (36)

VOLUME 9284

TODAY'S LOW / HIGH( ) 8641.00 9000.00

52 WK LOW / HIGH ( )6620.1 10691

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

6115.7

5590.9

5263.1

4804.8

Total Expenditure

5667.4

4839.1

4452

3941.1

PBIDT (Excl OI)

448.3

751.79

811.1

863.7

Other Income

51.3

61.7

112.4

161.5

Operating Profit

499.6

813.5

923.5

1025.2

Interest

10.6

6.7

7.2

6.8

Exceptional Items

14.8

-52.9

-3.6

-56.8

PBDT

503.8

753.9

912.7

961.6

Depreciation

38.4

25.7

165.7

176.9

Profit Before Tax

465.4

728.2

747

784.7

Tax

139.5

186

188.7

202.2

Provisions and contingencies

Profit After Tax

325.9

542.2

558.3

582.5

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

325.9

542.2

558.3

582.5

Equity Capital

Face Value (IN RS)

Reserves

Calculated EPS

13.03

21.68

22.33

23.3

Calculated EPS (Annualised)

52.14

86.75

89.32

93.20

No of Public Share Holdings

6250000

% of Public Share Holdings

PBIDTM% (Excl OI)

7.33

13.44

15.41

17.97

PBIDTM%

8.16

14.55

17.54

21.33

PBDTM%

8.23

13.48

17.34

20.01

PBTM%

7.60

13.02

14.19

16.33

PATM%

5.32

9.69

10.60

12.12

Notes

Risk Disclosures on Derivatives

Quarterly Results

ASTRAZENECA PHARMA INDIA LTD.